Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TEGAFUR\URACIL for Lung neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where TEGAFUR\URACIL was used for Lung neoplasm malignant.

Most Reported Side Effects for TEGAFUR\URACIL

Side Effect Reports % Deaths Hosp.
Neutropenia 23 18.7% 6 0
Diarrhoea 15 12.2% 3 6
Nausea 14 11.4% 2 4
Decreased appetite 13 10.6% 4 5
Fatigue 13 10.6% 3 3
Thrombocytopenia 11 8.9% 6 1
Anaemia 10 8.1% 6 2
Cardiac failure 9 7.3% 2 8
Leukopenia 9 7.3% 4 0
Neuropathy peripheral 8 6.5% 0 0
Palmar-plantar erythrodysaesthesia syndrome 8 6.5% 0 1
Disease progression 7 5.7% 3 0
Febrile neutropenia 7 5.7% 3 1
Vomiting 7 5.7% 1 2
Cerebral infarction 6 4.9% 0 5

Other Indications for TEGAFUR\URACIL

Colon cancer (10) Colorectal cancer (9) Colorectal cancer metastatic (9) Product used for unknown indication (7) Rectal cancer (6) Adenocarcinoma of colon (5) Breast cancer metastatic (5) Prostate cancer (5)

Other Drugs Used for Lung neoplasm malignant

ERLOTINIB (9,207) OSIMERTINIB (4,754) NIVOLUMAB (4,197) PEMBROLIZUMAB (3,575) CARBOPLATIN (3,487) ALECTINIB (2,932) PEMETREXED (2,422) CRIZOTINIB (1,949) BEVACIZUMAB (1,810) PACLITAXEL (1,747)

Related Pages

TEGAFUR\URACIL Full Profile All Lung neoplasm malignant Drugs TEGAFUR\URACIL Demographics TEGAFUR\URACIL Timeline